Login / Register for free to get access to My MedWorm

Current Opinion in Investigational DrugsCurrent Opinion in Investigational Drugs RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. subscribe with MyMedWormSubscribe to this data using MyMedWorm.subscribe with GoogleReaderSubscribe to this data using GoogleReader.subscribe with BloglinesSubscribe to this data using Bloglines.subscribe with MyYahooSubscribe to this data using MyYahoo.

This page shows you the latest items in this publication.

369 records returned

PI3K isoforms as drug targets in inflammatory diseases: Lessons from pharmacological and genetic strategiesemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
No description available (Source: Current Opinion in Investigational Drugs)
Source: Current Opinion in Investigational Drugs - October 27, 2009 Category: Drugs & Pharmacology Source Type: journals

The role of sphingosine-1-phosphate receptor modulators in the prevention of transplant rejection and autoimmune diseasesemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
No description available (Source: Current Opinion in Investigational Drugs)
Source: Current Opinion in Investigational Drugs - October 27, 2009 Category: Drugs & Pharmacology Source Type: journals

Paper alertemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
No description available (Source: Current Opinion in Investigational Drugs)
Source: Current Opinion in Investigational Drugs - October 27, 2009 Category: Drugs & Pharmacology Source Type: journals

Patent alertemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
No description available (Source: Current Opinion in Investigational Drugs)
Source: Current Opinion in Investigational Drugs - October 27, 2009 Category: Drugs & Pharmacology Source Type: journals

Editorial Overview - Something old, something new - Colchicine in the 21st centuryemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
No description available (Source: Current Opinion in Investigational Drugs)
Source: Current Opinion in Investigational Drugs - October 27, 2009 Category: Drugs & Pharmacology Source Type: journals

Gene therapy approaches to induce tolerance in autoimmunity by reshaping the immune systememail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
No description available (Source: Current Opinion in Investigational Drugs)
Source: Current Opinion in Investigational Drugs - October 27, 2009 Category: Drugs & Pharmacology Source Type: journals

FLAP inhibitors for the treatment of inflammatory diseasesemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
No description available (Source: Current Opinion in Investigational Drugs)
Source: Current Opinion in Investigational Drugs - October 27, 2009 Category: Drugs & Pharmacology Source Type: journals

Modulation of inflammatory disease by inhibitors of leukotriene A4 hydrolaseemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
No description available (Source: Current Opinion in Investigational Drugs)
Source: Current Opinion in Investigational Drugs - October 27, 2009 Category: Drugs & Pharmacology Source Type: journals

Regulation of osteoclast precursors in inflammatory bone lossemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
No description available (Source: Current Opinion in Investigational Drugs)
Source: Current Opinion in Investigational Drugs - October 27, 2009 Category: Drugs & Pharmacology Source Type: journals

Anti-cytokine antibodies for rheumatic diseasesemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
No description available (Source: Current Opinion in Investigational Drugs)
Source: Current Opinion in Investigational Drugs - October 27, 2009 Category: Drugs & Pharmacology Source Type: journals

AN-2728, a PDE4 inhibitor for the potential topical treatment of psoriasis and atopic dermatitisemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
No description available (Source: Current Opinion in Investigational Drugs)
Source: Current Opinion in Investigational Drugs - October 27, 2009 Category: Drugs & Pharmacology Source Type: journals

Palovarotene, a novel retinoic acid receptor gamma agonist for the treatment of emphysemaemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
No description available (Source: Current Opinion in Investigational Drugs)
Source: Current Opinion in Investigational Drugs - October 27, 2009 Category: Drugs & Pharmacology Source Type: journals

Paper alertemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
(Source: Current Opinion in Investigational Drugs)
Source: Current Opinion in Investigational Drugs - March 30, 2009 Category: Drugs & Pharmacology Authors: SA Antoniu, M Daneshtalab, S Doggrell, MJ Elices, RE Hurst, N Levens and M Williams Source Type: journals

Patent alertemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
(Source: Current Opinion in Investigational Drugs)
Source: Current Opinion in Investigational Drugs - March 30, 2009 Category: Drugs & Pharmacology Authors: HAM Mucke, P Norman, C Whelan and C Yeates Source Type: journals

The drugs from withinemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
(Source: Current Opinion in Investigational Drugs)
Source: Current Opinion in Investigational Drugs - March 30, 2009 Category: Drugs & Pharmacology Authors: FF Jr Bolander Source Type: journals

Endocannabinoids and reproductive endocrinologyemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
(Source: Current Opinion in Investigational Drugs)
Source: Current Opinion in Investigational Drugs - March 30, 2009 Category: Drugs & Pharmacology Authors: M Maccarrone Source Type: journals

Kisspeptin offers a novel therapeutic target in reproductionemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
(Source: Current Opinion in Investigational Drugs)
Source: Current Opinion in Investigational Drugs - March 30, 2009 Category: Drugs & Pharmacology Authors: CN Jayasena and WS Dhillo Source Type: journals

Aldosterone synthase inhibitors: Pharmacological and clinical aspectsemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
(Source: Current Opinion in Investigational Drugs)
Source: Current Opinion in Investigational Drugs - March 30, 2009 Category: Drugs & Pharmacology Authors: PM Jansen, den Meiracker AH van and AHJ Danser Source Type: journals

Treating diabetic retinopathy by inhibiting growth factor pathwaysemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
(Source: Current Opinion in Investigational Drugs)
Source: Current Opinion in Investigational Drugs - March 30, 2009 Category: Drugs & Pharmacology Authors: RN Frank Source Type: journals

Engineered antibodies for type 1 diabetesemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
(Source: Current Opinion in Investigational Drugs)
Source: Current Opinion in Investigational Drugs - March 30, 2009 Category: Drugs & Pharmacology Authors: CS Hampe Source Type: journals

The adipocyte IKK/NFkappaB pathway: A therapeutic target for insulin resistanceemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
(Source: Current Opinion in Investigational Drugs)
Source: Current Opinion in Investigational Drugs - March 30, 2009 Category: Drugs & Pharmacology Authors: H Ruan and HJ Pownall Source Type: journals

4-Hydroxyisoleucine: A plant-derived treatment for metabolic syndromeemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
(Source: Current Opinion in Investigational Drugs)
Source: Current Opinion in Investigational Drugs - March 30, 2009 Category: Drugs & Pharmacology Authors: L Jetté, L Harvey, K Eugeni and N Levens Source Type: journals

FGF21: A novel prospect for the treatment of metabolic diseasesemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
(Source: Current Opinion in Investigational Drugs)
Source: Current Opinion in Investigational Drugs - March 30, 2009 Category: Drugs & Pharmacology Authors: A Kharitonenkov and AB Shanafelt Source Type: journals

MF-101, an estrogen receptor beta agonist for the treatment of vasomotor symptoms in peri- and postmenopausal womenemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
(Source: Current Opinion in Investigational Drugs)
Source: Current Opinion in Investigational Drugs - March 30, 2009 Category: Drugs & Pharmacology Authors: DW Stovall and JV Pinkerton Source Type: journals

Corifollitropin alfa, a long-acting follicle-stimulating hormone agonist for the treatment of infertilityemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
(Source: Current Opinion in Investigational Drugs)
Source: Current Opinion in Investigational Drugs - March 30, 2009 Category: Drugs & Pharmacology Authors: D Loutradis, P Drakakis, A Vlismas and A Antsaklis Source Type: journals

INT-131, a PPARgamma agonist for the treatment of type 2 diabetesemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
(Source: Current Opinion in Investigational Drugs)
Source: Current Opinion in Investigational Drugs - March 30, 2009 Category: Drugs & Pharmacology Authors: U Kintscher and M Goebel Source Type: journals

Paper alertemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
(Source: Current Opinion in Investigational Drugs)
Source: Current Opinion in Investigational Drugs - March 2, 2009 Category: Drugs & Pharmacology Authors: SA Antoniu, M Daneshtalab, S Doggrell, MJ Elices, RE Hurst, N Levens and M Williams Source Type: journals

Patent alertemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
(Source: Current Opinion in Investigational Drugs)
Source: Current Opinion in Investigational Drugs - March 2, 2009 Category: Drugs & Pharmacology Authors: HAM Mucke, P Norman, C Whelan and C Yeates Source Type: journals

Drug development research: Diabetes favored over cardiovascular disease?email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
(Source: Current Opinion in Investigational Drugs)
Source: Current Opinion in Investigational Drugs - March 2, 2009 Category: Drugs & Pharmacology Authors: K Suckling Source Type: journals

Ischemic stroke intervention requires mixed cellular protection of the penumbraemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
(Source: Current Opinion in Investigational Drugs)
Source: Current Opinion in Investigational Drugs - March 2, 2009 Category: Drugs & Pharmacology Authors: FC Barone Source Type: journals

The use of lipid-lowering drug therapy in children and adolescentsemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
(Source: Current Opinion in Investigational Drugs)
Source: Current Opinion in Investigational Drugs - March 2, 2009 Category: Drugs & Pharmacology Authors: HJ Avis, MN Vissers, FA Wijburg, JJP Kastelein and BA Hutten Source Type: journals

The role of a murine transplantation model of atherosclerosis regression in drug discoveryemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
(Source: Current Opinion in Investigational Drugs)
Source: Current Opinion in Investigational Drugs - March 2, 2009 Category: Drugs & Pharmacology Authors: JE Feig, JS Quick and EA Fisher Source Type: journals

Reassessing the validity of surrogate markers of drug efficacy in the treatment of coronary artery diseaseemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
(Source: Current Opinion in Investigational Drugs)
Source: Current Opinion in Investigational Drugs - March 2, 2009 Category: Drugs & Pharmacology Authors: TJ Colatsky Source Type: journals

'Muscle-sparing' statins: Preclinical profiles and future clinical useemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
(Source: Current Opinion in Investigational Drugs)
Source: Current Opinion in Investigational Drugs - March 2, 2009 Category: Drugs & Pharmacology Authors: JA Pfefferkorn Source Type: journals

Soluble epoxide hydrolase: A new target for cardioprotectionemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
(Source: Current Opinion in Investigational Drugs)
Source: Current Opinion in Investigational Drugs - March 2, 2009 Category: Drugs & Pharmacology Authors: GJ Gross and K Nithipatikom Source Type: journals

NV1FGF, a pCOR plasmid-based angiogenic gene therapy for the treatment of intermittent claudication and critical limb ischemiaemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
(Source: Current Opinion in Investigational Drugs)
Source: Current Opinion in Investigational Drugs - March 2, 2009 Category: Drugs & Pharmacology Authors: N Maulik Source Type: journals

CYT-006-AngQb, a vaccine against angiotensin II for the potential treatment of hypertensionemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
(Source: Current Opinion in Investigational Drugs)
Source: Current Opinion in Investigational Drugs - March 2, 2009 Category: Drugs & Pharmacology Authors: S Phisitkul Source Type: journals

LA-419, a nitric-oxide donor for the treatment of cardiovascular disordersemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
(Source: Current Opinion in Investigational Drugs)
Source: Current Opinion in Investigational Drugs - March 2, 2009 Category: Drugs & Pharmacology Authors: IL Megson and SJ Leslie Source Type: journals

Paper alertemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
(Source: Current Opinion in Investigational Drugs)
Source: Current Opinion in Investigational Drugs - February 3, 2009 Category: Drugs & Pharmacology Authors: SA Antoniu, M Daneshtalab, S Doggrell, MJ Elices, RE Hurst and N Levens Source Type: journals

Patent alertemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
(Source: Current Opinion in Investigational Drugs)
Source: Current Opinion in Investigational Drugs - February 3, 2009 Category: Drugs & Pharmacology Authors: HAM Mucke, P Norman, C Whelan and C Yeates Source Type: journals

Old drugs resurrected?email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
(Source: Current Opinion in Investigational Drugs)
Source: Current Opinion in Investigational Drugs - February 3, 2009 Category: Drugs & Pharmacology Authors: JD Thomas, JG Moloughney and JH Toney Source Type: journals

Ribosomal frameshifting: An emerging drug target for HIVemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
(Source: Current Opinion in Investigational Drugs)
Source: Current Opinion in Investigational Drugs - February 3, 2009 Category: Drugs & Pharmacology Authors: PC Gareiss and BL Miller Source Type: journals

New approaches for inhibiting HIV integrase: A journey beyond the active siteemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
(Source: Current Opinion in Investigational Drugs)
Source: Current Opinion in Investigational Drugs - February 3, 2009 Category: Drugs & Pharmacology Authors: MA Walker Source Type: journals

Current developments in anti-HIV/AIDS gene therapyemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
No abstract available (Source: Current Opinion in Investigational Drugs)
Source: Current Opinion in Investigational Drugs - February 3, 2009 Category: Drugs & Pharmacology Authors: AY Tsygankov Source Type: journals

Treatment of multiresistant Acinetobacter baumannii infectionsemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
(Source: Current Opinion in Investigational Drugs)
Source: Current Opinion in Investigational Drugs - February 3, 2009 Category: Drugs & Pharmacology Authors: J Pachón and J Vila Source Type: journals

Challenges in developing new antibacterial drugsemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
(Source: Current Opinion in Investigational Drugs)
Source: Current Opinion in Investigational Drugs - February 3, 2009 Category: Drugs & Pharmacology Authors: KJ Williams and RP Bax Source Type: journals

Host defense peptides for use as potential therapeuticsemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
(Source: Current Opinion in Investigational Drugs)
Source: Current Opinion in Investigational Drugs - February 3, 2009 Category: Drugs & Pharmacology Authors: L Zhang and TJ Falla Source Type: journals

Addressing the challenge of extended-spectrum beta-lactamasesemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
(Source: Current Opinion in Investigational Drugs)
Source: Current Opinion in Investigational Drugs - February 3, 2009 Category: Drugs & Pharmacology Authors: J-R Zahar, O Lortholary, C Martin, G Potel, P Plesiat and P Nordmann Source Type: journals

Boceprevir, an NS3 serine protease inhibitor of hepatitis C virus, for the treatment of HCV infectionemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
(Source: Current Opinion in Investigational Drugs)
Source: Current Opinion in Investigational Drugs - February 3, 2009 Category: Drugs & Pharmacology Authors: I Mederacke, H Wedemeyer and MP Manns Source Type: journals

Elvitegravir, an oral HIV integrase inhibitor, for the potential treatment of HIV infectionemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
(Source: Current Opinion in Investigational Drugs)
Source: Current Opinion in Investigational Drugs - February 3, 2009 Category: Drugs & Pharmacology Authors: OM Klibanov Source Type: journals